Funding Status: Early Stage Venture
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2021-01-01
Last Funding Type: Series A
Total Funding: 100000000.0
Industry: Early Drug Development
Investors Number: 6.0
Last Funding Date: 2022-10-14